Differences in SARS-CoV-2 antigen persistence in individuals with systemic autoimmune rheumatic diseases compared to the general population: A RECOVER-Adult Cohort Study
Listen to this summary
This study investigates whether individuals with systemic autoimmune rheumatic diseases (SARDs) exhibit longer persistence of SARS-CoV-2 antigens compared to the general population following COVID-19 infection. The findings reveal that individuals with SARDs have significantly higher rates of antigen positivity at both 3 and 6 months post-infection, suggesting a prolonged viral presence that is not attributable to demographic factors, vaccination status, or treatment.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.

More from Arthritis & rheumatology (Hoboken, N.J.)
View all →May 8, 2026 · Arthritis & rheumatology (Hoboken, N.J.)
T cell plasticity in systemic lupus erythematosus revealed by large-scale T cell receptor repertoire and transcriptome studies
May 7, 2026 · Arthritis & rheumatology (Hoboken, N.J.)
Gender equity in rheumatology research: global analysis of authors
May 7, 2026 · Arthritis & rheumatology (Hoboken, N.J.)
B-cell Maturation Antigen Targeted Chimeric Antigen Receptor T-cell Therapy for Refractory Systemic Lupus Erythematosus and Systemic Sclerosis
May 6, 2026 · Arthritis & rheumatology (Hoboken, N.J.)
Therapeutic targeting protein kinase CK2 ameliorates lupus nephritis by modulating neutrophil infiltration and neutrophil extracellular trap formation
May 4, 2026 · Arthritis & rheumatology (Hoboken, N.J.)
Increased Risk of Intrahepatic Cholestasis of Pregnancy in SLE Women Exposed to Azathioprine
May 1, 2026 · Arthritis & rheumatology (Hoboken, N.J.)
Pediatric Rheumatology Symposium 2026 Abstract Supplement
More in Internal Medicine
View all →May 10, 2026 · JAMA
Digoxin in Patients With Symptomatic Rheumatic Heart Disease: A Randomized Clinical Trial
May 10, 2026 · European heart journal
Blinded withdrawal of randomized treatment with low-dose digoxin or placebo in patients with heart failure: the DECISION trial
May 10, 2026 · Lancet (London, England)
Endovascular thrombectomy for patients with large-core ischaemic stroke presenting up to 24 h after onset (ATLAS): a systematic review and individual patient data meta-analysis with central imaging adjudication
May 10, 2026 · European heart journal
Renin-angiotensin-aldosterone system inhibition and haemocompatibility-related adverse events in patients with durable left ventricular assist device: the MOMENTUM-3 trial
May 10, 2026 · JAMA
Efficacy and Safety of Digitalis Glycosides in Heart Failure: A Meta-Analysis
May 10, 2026 · Lancet (London, England)
Impact of introducing RTS,S/AS01<sub>E</sub> malaria vaccine on mortality in young children in Ghana, Kenya, and Malawi: an observational evaluation of a cluster-randomised implementation programme
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR


